2nd Quarter - Report
TODD STRATEGY GROUP for GENENTECH, INC.
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription drug payment reform. Supply chain. Strategic National Stockpile.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC BERGREN | — |
| KATHERINE FLEMING COTTON | — |
| PAUL EDATTEL | — |
| NICOLAS MAGALLANES | — |
| DANIEL M TODD | — |
Medicare/Medicaid MMM
Medicare and Medicaid payment issues. 340B. Implementation of Inflation Reduction Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC BERGREN | Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker |
| KATHERINE FLEMING COTTON | Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie |
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg |
| NICOLAS MAGALLANES | Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander |
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.